Merck KGaA’s US biopharmaceutical business EMD Serono has appointed Richard Smith as senior vice president and head of US fertility and endocrinology.
Smith will take on responsibility for the two businesses as well as the firm’s fertility technologies division, which launched its first medical device last year.
He joins EMD Serono from Novartis, where he spent the last 18 years in a series of roles across the company’s commercial business, most recently as vice president and US head of sales and operations of its cardiovascular franchise.
Prior to this role, Smith served as executive director and head of Novartis’ transplant franchise, as well as positions in customer segment marketing, strategy and commercial operations for specialty medicines, brand managed markets strategy, and pricing and contracting for its neuroscience franchise.
Gary Zieziula, president and managing director of EMD Serono, said: “We have a longstanding focus on providing comprehensive solutions in the areas of fertility and endocrinology care through innovative products as well as financial, educational and emotional support.
“Adding Richard’s expertise, passion and industry knowledge to our strong and committed team will ensure that we are well-positioned to further meet the needs of patients and customers.”